| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 31282-04-9 | 潮霉素B | Hygromycin B; O-6-Amino-6-deoxy-L-glycero-D-galacto-heptopyranosylidene-(1-2-3)-o-beta-D-talopyranosyl-(1-5)-2-deoxy-N3-methyl-D-streptamine | ![]() | C20H37N3O13 | 詳情 | 供應(yīng)商 |
| 7491-09-0 | 1,2-二(2-乙基己基氧碳基)乙烷磺酸鉀 | Potassium, 1,2-bis(2-ethylhexyloxycarbonyl) ethanesulphonate; Dioctyl potassium sulfosuccinate; potassium 1,2-bis(2-ethylhexyloxycarbonyl)ethanesulphonate; Potassium,1,2-bis(2-ethylhexyloxycarbonyl)ethanesulphonate | ![]() | C20H37KO7S | 詳情 | 供應(yīng)商 |
| 35425-17-3 | Acetic acid,2,2,2-trichloro-, octadecyl ester; Aceticacid, trichloro-, octadecyl ester (9CI); Octadecyl trichloroacetate | ![]() | C20H37Cl3O2 | 詳情 | 供應(yīng)商 | |
| 72102-49-9 | Butanedioicacid, 2-sulfo-, 1,4-dioctyl ester, potassium salt (1:1); Butanedioicacid, sulfo-, 1,4-dioctyl ester, potassium salt (9CI) | ![]() | C20H37KO7S | 詳情 | 供應(yīng)商 | |
| 23384-85-2 | Carbamic acid,dicyclohexyl-, 2-piperidinoethyl ester, monohydrochloride (8CI); Carbamicacid, dicyclohexyl-, 2-piperidinoethyl ester, hydrochloride (6CI); 1-Piperidineethanol, dicyclohexylcarbamate (ester), monohydrochloride (8CI) | ![]() | C20H37ClN2O2 | 詳情 | 供應(yīng)商 | |
| 202480-70-4 | Eicosanoic-20,20,20-d3acid (9CI); ARACHIDIC ACID (METHYL-D3); EICOSANOIC-20,20,20-D3 ACID; EICOSANOIC ACID (METHYL-D3) | ![]() | C20H37D3O2 | 詳情 | 供應(yīng)商 | |
| 27545-11-5 | Glycine,N-[N-[N-[(1,1-dimethylethoxy)carbonyl]-L-leucyl]-L-leucyl]-, methyl ester (9CI); Glycine,N-[N-(N-carboxy-L-leucyl)-L-leucyl]-, N-tert-butyl methyl ester (8CI); NSC136983 | ![]() | C20H37N3O6 | 詳情 | 供應(yīng)商 | |
| 102814-04-0 | Glycine, L-g-glutamyl-S-decyl-L-cysteinyl-; Glycine,N-(S-decyl-N-L-g-glutamyl-L-cysteinyl)-; S-(n-Decyl)glutathione; S-Decyl-GSH; S-Decylglutathione | ![]() | C20H37N3O6S | 詳情 | 供應(yīng)商 | |
| 110044-82-1 | 鈣蛋白酶抑制劑I; N-乙酰基-L-亮氨酰-L-亮氨酰-L-正亮氨醛 | L-Leucinamide,N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-; L-Leucinamide,N-acetyl-L-leucyl-N-(1-formylpentyl)-, (S)-; ALLN; ALLnL; CI-1 (peptide); CalpI; Calpain inhibitor I; MG 101; N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal | ![]() | C20H37N3O4 | 詳情 | 供應(yīng)商 |
| 105467-53-6 | L-Leucinamide,N-acetyl-L-leucyl-N-(1-formyl-3-methylbutyl)- (9CI); SUAM 314 | ![]() | C20H37N3O4 | 詳情 | 供應(yīng)商 | |
| 105467-52-5 | L-Leucinamide,N-acetyl-L-leucyl-N-(1-formylpentyl)- (9CI); SUAM 313 | ![]() | C20H37N3O4 | 詳情 | 供應(yīng)商 | |
| 158164-29-5 | Hydrazinium,1-[2-hydroxy-3-(isononylphenoxy)propyl]-1,1-dimethyl-, chloride (9CI); Tyumen 3 | ![]() | C20H37ClN2O2 | 詳情 | 供應(yīng)商 | |
| 102366-82-5 | Hexanediamide,N1,N1-bis(1,1-dimethylethyl)-3-(2-nitrocyclohexyl)-; 3-(2-nitrocyclohexyl)-N,N-ditert-butyl-hexanediamide | ![]() | C20H37N3O4 | 詳情 | 供應(yīng)商 | |
| 82040-44-6 | Octadecanoic acid,9-(trichloromethyl)-, methyl ester | ![]() | C20H37Cl3O2 | 詳情 | 供應(yīng)商 | |
| 5462-64-6 | 1,2-Benzenediamine,N2-[6-(diethylamino)hexyl]-4,5-dimethoxy-N1,N1-dimethyl-; o-Phenylenediamine,N-[6-(diethylamino)hexyl]-4,5-dimethoxy-N,N-dimethyl- (8CI); NSC 13289 | ![]() | C20H37N3O2 | 詳情 | 供應(yīng)商 | |
| 95998-63-3 | 18-Nonadecenoic acid,19-iodo-3-methyl-, (18E)-; 18-Nonadecenoicacid, 19-iodo-3-methyl-, (E)- (9CI); 18-Nonadecenoic acid, 19-iodo-3-methyl-,(E)-(?à)- | ![]() | C20H37IO2 | 詳情 | 供應(yīng)商 | |
| 103213-61-2 | 11-Eicosenoyl chloride,(11Z)-; 11-Eicosenoylchloride, (Z)- | ![]() | C20H37ClO | 詳情 | 供應(yīng)商 | |
| 138146-66-4 | 2-Butenoic acid,2-[[(3S)-3-[[(3S)-3-amino-1-oxooctyl]amino]-1-oxooctyl]amino]-; Dioctatin B | ![]() | C20H37N3O4 | 詳情 | 供應(yīng)商 | |
| 14918-35-5 | 德利肥素(DESTONATE) | destomycin A; destomycin A; Destonmycin A; 5-O-[2-O,3-O-(6-Amino-1,6-dideoxy-L-glycero-D-galacto-heptopyranos-1-ylidene)-β-D-talopyranosyl]-2-deoxy-N1-methyl-D-streptamine; Destonate 20 | ![]() | C20H37N3O13 | 詳情 | 供應(yīng)商 |
| 79392-43-1 | Octadecyl trifluoroacetate | ![]() | C20H37F3O2 | 詳情 | 供應(yīng)商 | |